Production of antigenic proteins for the development of new clinical tests detecting in quelques minutes the antibodies expressed following an infection with COVID-19

The National Center for Electrochemistry and Environmental Technologies (CNETE) wishes to produce antigenic proteins from the SARS-COV-2 virus. These proteins will be produced using non-pathogenic bacteria and yeast in order to manipulate them safely and without the risk of infection. These proteins can be used to develop new, simple and rapid clinical tests. Among other things, these proteins will be used by the company Affinité Instruments to develop a clinical test to measure, in a few minutes, the antibodies expressed following a COVID-19 infection, thus making it possible to screen the population. who is now immune. This will help identify people who are not likely to become infected such as personnel providing essential services and medical care. These antigenic proteins can also be used to create new vaccines and will be accessible to the whole community Canadian scientist. The benefits of the project are therefore significant for the CNETE, for Affinité Instruments and for Canada.